stockrow
Friday 6 November 2026
Export CHSCP’s income statement to Excel — free account
CHS Inc
CHSCP Consumer Defensive Farm Products
CHS Inc’s revenue for fiscal 2026 (year ended August 2026) was $39.2 billion, up 10.6% from fiscal 2025.
- Revenue
- +21.2%
- Free cash flow
- +25.9%
- Total debt
- +11.8%
Quarter to August 2026, against a year earlier
25.56
0.05
−0.20%
Follow CHSCP
Alert me
| Older periods | Nov '25 | Feb '26 | May '26 | Aug '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.04 | 0.05 | 0.04 | 0.05 | |
EV/EBITDA |
1.94 | 2.71 | 2.21 | 1.41 | |
EV/Operating CF |
2.46 | 1.78 | 1.11 | 1.13 | |
EV/FCF |
(4.97) | 7.14 | 1.80 | 1.65 | |
Quick Ratio |
0.63 | 0.54 | 0.74 | 0.73 | |
Current Ratio |
1.42 | 1.45 | 1.47 | 1.68 | |
Net Debt/EBITDA |
4.98 | (27.24) | 5.98 | 2.32 | |
Debt/Assets |
8.82% | 10.20% | 10.27% | 10.21% | |
Debt/Equity |
0.16 | 0.19 | 0.19 | 0.18 | |
Asset Turnover |
1.74 | 1.74 | 1.85 | 2.01 | |
Operating CF/Net income |
(1.30) | 3.87 | 4.14 | 1.93 | |
Capex/Depreciation |
(0.68) | (0.64) | (1.00) | (0.65) | |
Interest Coverage |
3.25 | (5.53) | 2.18 | 18.42 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
3.02% | 3.20% | 2.61% | 3.43% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(453.33) | (679.84) | 943.53 | 1,273.20 | |
Working Capital |
2,931.83 | 3,174.51 | 3,171.97 | 3,792.72 | |
Capital Expenditures |
(115.51) | (110.82) | (164.52) | (109.59) | |
Net Current Asset Value |
363.53 | 407.71 | 371.01 | 931.93 | |
EV/EBIT |
19.62 | 435.34 | 39.23 | 3.02 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
3,864.73 | 3,497.98 | 4,370.02 | 3,770.70 | |
Average Payables |
3,568.20 | 2,717.08 | 2,885.15 | 2,828.03 | |
Average Inventory |
4,114.44 | 4,765.53 | 3,528.83 | 3,626.90 | |
Average Assets |
20,159.85 | 20,503.95 | 20,232.27 | 19,488.37 | |
Average Common Equity |
8,748.57 | 8,623.17 | 8,732.88 | 9,098.47 |
Columns are period end dates · fundamentals updated 6 Nov 2026